TECTONIC THERAPEUTIC, INC. Increase (Decrease) in Restricted Cash
TECTONIC THERAPEUTIC, INC. (TECX) reported Increase (Decrease) in Restricted Cash of $259.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2019-11-07
- TECTONIC THERAPEUTIC, INC. increase (decrease) in restricted cash for the quarter ending 2018-09-30 was $283.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month |
|---|---|---|---|
| 2018-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $259.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$24.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |